34 related articles for article (PubMed ID: 17323978)
1. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
[TBL] [Abstract][Full Text] [Related]
2. Rat hormone sensitive lipase inhibition by cyclipostins and their analogs.
Vasilieva E; Dutta S; Malla RK; Martin BP; Spilling CD; Dupureur CM
Bioorg Med Chem; 2015 Mar; 23(5):944-52. PubMed ID: 25678014
[TBL] [Abstract][Full Text] [Related]
3. Exposure to tri-o-cresyl phosphate detected in jet airplane passengers.
Liyasova M; Li B; Schopfer LM; Nachon F; Masson P; Furlong CE; Lockridge O
Toxicol Appl Pharmacol; 2011 Nov; 256(3):337-47. PubMed ID: 21723309
[TBL] [Abstract][Full Text] [Related]
4. Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.
Carletti E; Schopfer LM; Colletier JP; Froment MT; Nachon F; Weik M; Lockridge O; Masson P
Chem Res Toxicol; 2011 Jun; 24(6):797-808. PubMed ID: 21438623
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates.
Makhaeva GF; Aksinenko AY; Sokolov VB; Baskin II; Palyulin VA; Zefirov NS; Hein ND; Kampf JW; Wijeyesakere SJ; Richardson RJ
Chem Biol Interact; 2010 Sep; 187(1-3):177-84. PubMed ID: 20035729
[TBL] [Abstract][Full Text] [Related]
6. Structural approach to the aging of phosphylated cholinesterases.
Masson P; Nachon F; Lockridge O
Chem Biol Interact; 2010 Sep; 187(1-3):157-62. PubMed ID: 20338153
[TBL] [Abstract][Full Text] [Related]
7. Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.
Lockridge O; Norgren RB; Johnson RC; Blake TA
Chem Res Toxicol; 2016 Sep; 29(9):1381-92. PubMed ID: 27551784
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
[TBL] [Abstract][Full Text] [Related]
9. The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss.
Kropp TJ; Glynn P; Richardson RJ
Biochemistry; 2004 Mar; 43(12):3716-22. PubMed ID: 15035642
[TBL] [Abstract][Full Text] [Related]
10. Aging of mipafox-inhibited human acetylcholinesterase proceeds by displacement of both isopropylamine groups to yield a phosphate adduct.
Kropp TJ; Richardson RJ
Chem Res Toxicol; 2006 Feb; 19(2):334-9. PubMed ID: 16485911
[TBL] [Abstract][Full Text] [Related]
11. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
12. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers.
Doorn JA; Schall M; Gage DA; Talley TT; Thompson CM; Richardson RJ
Toxicol Appl Pharmacol; 2001 Oct; 176(2):73-80. PubMed ID: 11601883
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
